WIC
CERE

Water Island Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Water Island Capital’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-766,933
Closed -$31.4M – 95
2024
Q2 		$31.4M Sell
766,933
-21,937
-3% -$914K 3.18% 14
2024
Q1 		$33.3M Buy
788,870
+200,770
+34% +$8.43M 3.47% 17
2023
Q4 		$24.9M Buy
+588,100
New +$16.9M 2.46% 16

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Water Island Capital's CERE Position: Q3 2024 in Review

Water Island Capital sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 766,933 shares — an estimated $31.4M sold.

Water Island Capital first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $33.3M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Water Island Capital reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Water Island Capital sold 766,933 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $31.4M.
  • Water Island Capital first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Water Island Capital's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $33.3M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Water Island Capital's 13F filing for Q3 2024, filed 14 Nov 2024.